Not applicableLooking for participantsNCT04706754What this trial is testingPan-Canadian Lung Cancer Observational Study (PALEOS)Who this might be right forLung Cancer William Osler Health System 25,000
Testing effectiveness (Phase 2)Looking for participantsNCT04566380What this trial is testingONO-4538 Phase II Rollover Study (ONO-4538-98)Who this might be right forPan-tumor Ono Pharmaceutical Co., Ltd. 59
Testing effectiveness (Phase 2)Active Not RecruitingNCT05585320What this trial is testingA Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid TumorPancreatic AdenocarcinomaMalignant Melanoma (Cutaneous)+1 more Immuneering Corporation 209
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06991491What this trial is testingIvonescimab With GnP and SBRT in Patients With Metastatic Pancreatic Cancer (WGOG-PAN 004)Who this might be right forPancreatic Cancer West China Hospital 29
Not applicableUnknownNCT05685524What this trial is testingClinical Study of Pan-cancer DNA Methylation Test in PlasmaWho this might be right forCancer Wuhan Ammunition Life-tech Co., Ltd 3,000
Not applicableStudy completedNCT07643389What this trial is testingEXCEL-Punjabi: A Culturally Tailored Exercise Oncology Pilot Feasibility InterventionWho this might be right forCancer University of Calgary 12
Not applicableLooking for participantsNCT06822413What this trial is testingRaman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early DiagnosisWho this might be right forCancer DiagnosisLiver Cancer, AdultCancer Screening+14 more Second Affiliated Hospital, Zhejiang University, School of Medicine 600
Testing effectiveness (Phase 2)Looking for participantsNCT04645160What this trial is testingEvaluating Efficacy of Tivozanib (AV-951) in Biliary Tract CancersWho this might be right forCholangiocarcinomaBile Duct NeoplasmBiliary Tract Malignancy National Cancer Institute (NCI) 31
Not applicableLooking for participantsNCT06605404What this trial is testingPan-tumor MRD StudyWho this might be right forMuscle Invasive Bladder Urothelial CarcinomaEsophageal CancerGastric and Gastroesophageal Junction (GEJ) Adenocarcinoma+4 more Paradigm Health 1,350
Testing effectiveness (Phase 2)Study completedNCT01816984What this trial is testingPI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck CancerWho this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+33 more University of Chicago 12
Early research (Phase 1)Study completedNCT01976741What this trial is testingDose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)Who this might be right forNeoplasms Bayer 168
Not applicableStudy completedNCT01486251What this trial is testingAssessment of Tumor Vascular Effects of Axitinib With Dynamic Ultrasonography in Patients With Metastatic Colorectal CancerWho this might be right forColorectal Carcinoma Gustave Roussy, Cancer Campus, Grand Paris 27
Testing effectiveness (Phase 2)Ended earlyNCT02906670What this trial is testingSym013 (Pan-HER) in Patients With Advanced Epithelial MalignanciesWho this might be right forOncology Symphogen A/S 32
Early research (Phase 1)Study completedNCT01004224What this trial is testingA Dose Escalation Study in Adult Patients With Advanced Solid MalignanciesWho this might be right forAdvanced Solid Tumors With Alterations of FGFR1, 2 and or 3Squamous Lung Cancer With FGFR1 AmplificationBladder Cancer With FGFR3 Mutation or Fusion+3 more Novartis Pharmaceuticals 208
Early research (Phase 1)Ended earlyNCT02795819What this trial is testingStudy of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney CancerWho this might be right forRenal Cell CarcinomaSoft Tissue SarcomaMetastatic Disease Virginia Commonwealth University 6
Testing effectiveness (Phase 2)Study completedNCT01728233What this trial is testingDacomitinib (PF-00299804) in Advanced/Metastatic Squamous Cell Carcinoma of the PenisWho this might be right forPenile NeoplasmsCarcinoma, Squamous Cell Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 32
Testing effectiveness (Phase 2)WithdrawnNCT02575508What this trial is testingPan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic CancerWho this might be right forColon AdenocarcinomaMetastatic Pancreatic AdenocarcinomaPancreatic Adenocarcinoma+14 more Roswell Park Cancer Institute
Not applicableActive Not RecruitingNCT03421132What this trial is testingMultiple Myeloma Molecular Monitoring StudyWho this might be right forMultiple Myeloma Horizon Health Network 96
Not applicableActive Not RecruitingNCT04405557What this trial is testingThe PREDICT Study: Prospective Early Detection In a Population at High-risk for Common Malignant TumorWho this might be right forEarly Detection of Cancer Geneplus-Beijing Co. Ltd. 757
Testing effectiveness (Phase 2)UnknownNCT03770988What this trial is testingA Trial to Evaluate the Efficacy of Poziotinib, Pan HER Inhibitor in Recurrent/Metastatic Esophageal Cancer (R/M ESCC)Who this might be right forInoperable or Recurrent or Metastatic Esophageal Squamous Carcinoma Yonsei University 49